News

Researchers create new identification method for drug and drug combinations that may combat resistant infections.

A way to reduce cancer cell development, brought on as a byproduct of gene therapy, has been developed.

SeraCare Life Sciences collaborates with ArcherDX on RNA Fusion Reference Standards.

Monitoring cancer DNA in blood can predict recurrence and prognosis and drive treatment decisions.

The expanded capacity will support larger scale spray drying programs to 100 kg scale as BioDuro continues pursuit of its clients’ clinical success.

In a study of patients with cardiovascular disease, researchers concluded that high-intensity statin treatments increased rates of survival.

Company has secured an agreement with Menarini Group to deliver controlled release pellets for one of its products.

The facility has advanced technical transfer capabilities and expertise in the development of chemical processes and analytical methods up to registration on a global basis.

Acquisition to complement UPS healthcare logistics solutions transaction highlights.

Under the agreement, company will supply cell-free DNA-based molecular reference standards for inclusion in CareDx’s cfDNA testing workflows for the monitoring of transplanted organ rejection.